These findings emphasise the complex, context-dependent role of chemokine signalling in cancer, with CCL4 enhancing T-cell infiltration, CCL5 mediating both immune activation and suppression [252], and CCL22 driving immune evasion through Treg recruitment. Here, CCL22 is linked to cancer.